High Growth Tech Stocks In Hong Kong Featuring Alibaba Pictures Group And Two More

In This Article:

As global markets react to the Federal Reserve's recent rate cut, Hong Kong's tech sector has shown resilience and potential for growth, with the Hang Seng Index gaining over 5% in a holiday-shortened week. In this article, we will explore three high-growth tech stocks in Hong Kong, including Alibaba Pictures Group, highlighting what makes them promising investments in the current market landscape.

Top 10 High Growth Tech Companies In Hong Kong

Name

Revenue Growth

Earnings Growth

Growth Rating

Wasion Holdings

22.37%

25.47%

★★★★★☆

MedSci Healthcare Holdings

48.74%

48.78%

★★★★★☆

Inspur Digital Enterprise Technology

25.37%

39.10%

★★★★★☆

RemeGen

26.30%

52.19%

★★★★★☆

Akeso

33.07%

54.67%

★★★★★★

Cowell e Holdings

31.82%

35.43%

★★★★★★

Innovent Biologics

22.35%

59.39%

★★★★★☆

Sichuan Kelun-Biotech Biopharmaceutical

24.70%

8.53%

★★★★★☆

Biocytogen Pharmaceuticals (Beijing)

21.53%

109.17%

★★★★★☆

Beijing Airdoc Technology

37.47%

93.35%

★★★★★☆

Click here to see the full list of 45 stocks from our SEHK High Growth Tech and AI Stocks screener.

Let's uncover some gems from our specialized screener.

Alibaba Pictures Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Alibaba Pictures Group Limited, an investment holding company, operates in the content, technology, and IP merchandising and commercialization businesses in Hong Kong and the People's Republic of China with a market cap of HK$10.99 billion.

Operations: Alibaba Pictures Group Limited generates revenue primarily from five segments: Film Investment, Production, Promotion and Distribution (CN¥2.07 billion), IP Merchandising and Commercialization (CN¥1.05 billion), Film Ticketing and Technology Platform (CN¥920.22 million), Drama Series Production (CN¥596.12 million), and Damai (CN¥394.28 million).

Alibaba Pictures Group, amidst evolving its bylaws, demonstrates a robust trajectory in the entertainment sector with a projected revenue growth of 13.4% annually, outpacing Hong Kong's average of 7.3%. This growth is complemented by an even more impressive earnings forecast, expected to surge at 35.4% per year, significantly ahead of the local market's 11.8%. These figures underscore a strategic pivot towards optimizing operational frameworks and capitalizing on market opportunities, despite past challenges marked by a substantial one-off loss of CN¥353.2M last fiscal year. The company's recent amendments to its bye-laws could further streamline operations and enhance shareholder engagement as it navigates through competitive landscapes and shifting consumer demands.